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Background: Generally accepted, but insuﬃciently proved, the concept of synergy is based on an assumption
that combining of two biologically active substances is justiﬁed because the combination is more active and
less harmful than the ingredients.
Hypothesis: Analysis of RNA microarray of isolated neuroglia cells and the comparison the number of genes
deregulated by plant extracts and their ﬁxed herbal formulation might be a useful tool/method for assess-
ment of synergistic and antagonistic interactions of herbal extracts in human organism.
Aim: The primary aim of this study was to extend a new method of assessment of synergistic and antago-
nistic interactions of herbal extracts in isolated human neuroglia cells when they applied in the form of ﬁxed
combinations. The secondary aim of the study was to predict possible effects of Herba Andrographidis (APE),
Radix Eleutherococci (ESE) genuine extracts and their ﬁxed combination Kan Jang (KJ) on cellular and phys-
iological functions and associated diseases. The third task of the study was to ﬁnd evidences that justify the
hypothesis that these plants extracts in combination are more useful than the monodrugs.
Methods: Gene expression proﬁling was performed on the human neuroglia cell line T98G after treatment
with APE, ESE, KJ and total number of more than two fold-deregulated genes from all experiments were com-
pared by Venn diagram. Interactive pathways downstream analysis was performed with data sets of signiﬁ-
cantly up– or down-regulated genes and predicted effects on cellular functions and diseases were identiﬁed
by Ingenuity IPA database software.
Results: ESE and APE signiﬁcantly deregulate 207 and 211 genes correspondingly; 36 deregulated genes were
common for both extracts. In total of 382 deregulated genes was expected to be deregulated by their ﬁxed
combination KJ. However, it was found only 250 genes deregulated by KJ. Among these 250 genes, 111 genes
were unique for the KJ combination and not affected by ESE and APE. This is presumably due to synergistic
interactions of molecular networks affected by ESE and APE. Meanwhile, 170 genes deregulated by ESE, and
55 genes deregulated by APE when tested alone, were not up- or downregulated by KJ. That is the result of
antagonistic integrations of ESE and APE extracts when applied in the combination. Fold change of expression
of 18 common genes deregulated by APE, ESE and KJ was not additive when APE and ESE are combined in
KJ herbal formula. However, a qualitative difference is observed in the ﬁngerprint of deregulated genes of
daughter substance (KJ) compared to ﬁngerprints/signatures of deregulated genes of parent substances (APE
and ESE).
Speciﬁc for KJ and predictable (z-score > 2) were the effects on pathways and networks associated with
infectious and chronic inﬂammatory disorders, namely encephalitis or neurological movement disorders.
Noteworthy, Eleutherococcus alone has no effect on those networks, particularly on encephalitis network,
while KJ deregulates 11 genes which have predictable inhibitory effect on infection, while APE regulates
Abbreviations: APE, Andrographis paniculata L. Nees. (herb) genuine extract; EL,
eleutherosides B and E; ESE, Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (root)
genuine extracts; IPA, Ingenuity Pathway Analysis software; KJ, Kan Jang ﬁxed combi-
nation of APE and ESE.
∗ Corresponding author. Tel.: +46702818171; fax: +46 430 23723.
E-mail address: alexander.panossian@shi.se, ap.phytomedicine@gmail.com (A.
Panossian).
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(Introduction
The idea to combine two or more plant extracts in one pre-
sumably more effective combination traced back many centuries.
There are numerous examples of complex formulations widely used
in traditional Chinese medicine and other traditional medicines
worldwide.
The generally accepted, but insuﬃciently proved concept of syn-
ergy is based on the assumption that combining two substances,
which act on different molecular targets in cells, may result in ad-
ditive or supra-additive responses in cells or organisms, due to syn-
ergistic interactions of molecular targets within their molecular net-
works (Wagner 2006; Efferth and Koch 2011). A priori accepted is also
the assumption that ﬁxed combinations have the same characteris-
tic features as their single constituents. In other words, at least ad-
ditive effects can be expected for ﬁxed combinations. However, our
recent study (Panossian et al. 2013) showed that it is actually not
true: the combination of three plant extracts may not exhibit some
effects that single ingredients have. At the same time, it may ex-
ert some new and unique features, which the constituents do not
reveal.
In this article, we extend this observation to another combination
of plant extracts and explore a novel method of synergy assessment
of herbal extracts in their ﬁxed combination. The method is based
on the analysis of transcriptome-wide microarray-based mRNA ex-
pression proﬁling as previously described by us for the ﬁrst time
(Panossian et al. 2013). In that study, isolated brain cells were sep-
arately incubated with three plant extracts, Rhodiola, Eleuterococcus
and Schisandra or their ﬁxed combination (Panossian et al. 2013). The
total numbers of more than two fold-deregulated genes from all ex-
periments were compared by Venn diagram. The number of genes
deregulated by the combination, but not by any constituent alone
provided evidence of synergistic interaction of the ingredients in the
ﬁxed combination. This is actually the essence of the new analysis
method of synergy effects.
In present study, two well-known plants Andrographis panicu-
lata L. Nees. (herb), Acanthaceae (Herba Andrographidis 2002) and
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (root), Arali-
aceae (Radix Eleutherococci 2002; ESCOP Monographs 2003) gen-
uine extracts and their ﬁxed combination, Kan Jang (Panossian and
Wikman 2012), standardized for the content of andrographiolides
and eleutherosides, were explored.
The leaves and aerial parts of A. paniculata have been used
for prophylactic and symptomatic treatment of respiratory infec-
tions, such as common cold, inﬂuenza with fever, sore throat,
acute and chronic cough, sinusitis, bronchitis and pharyngotonsilli-
tis (Herba Andrographidis 2002; Herba Andrographis (Chuanxinlian)
2010). Commonly found in tropical and subtropical regions, A.
paniculata is currently one of the most used medicinal plants ind in encephalitis. It can be speculated that APE in combination with ESE
ect, since more targets are affected. Similar suggestion is justiﬁed regarding
is associated with chronic inﬂammation, like arthritis and osteoarthrosis.
not provide ﬁnal proof that the genes induced by the KJ, APE and ESE are
l effects observed in humans following their oral administration. It provided
directions for future research and possible implementation into practice.
ed canonical pathways deregulated by KJ and APE was interferon signaling
effectiveness of KJ and APE in the treatment of severe sepsis, systemic lupus
mune diseases
croarray data from isolated neuroglia cells and the comparison the number
tracts and their ﬁxed herbal formulation might be a useful tool/method for
tagonistic interactions of herbal extracts in human organism. Combination
is most likely justiﬁed.
© 2015 Elsevier GmbH. All rights reserved.
outheast Asia. As antipyretic treatment, it is effective against a wide
ariety of infection diseases, including urinary infections with diﬃ-
ult painful urination, tonsillitis, dysentery, edema, bacillary dysen-
ery, bronchitis, carbuncles, colitis, coughs, dyspepsia, malarial and
ntermittent fever, hepatitis, mouth ulcers, sores, tuberculosis, colic,
titis media, vaginitis, pelvic inﬂammatory disease, chickenpox, and
czema. The plant is also effective for the treatment of carbuncles,
ores, venomous snake bites, ulcers in the mouth or on the tongue,
iver disorders, burns and traumatic infections. Remarkably, eﬃcacy
as demonstrated in clinical studies for prophylaxis and treatment
f upper respiratory infections, such as the common cold, uncompli-
ated sinusitis, bronchitis and pharyngotonsillitis, urinary tract infec-
ions, and acute diarrhea [Herba Andrographidis 2002].
E. senticosus is an adaptogenic plant, which increases the state
f non-speciﬁc resistance against a wide variety of environmental
ssaults and emotional conditions (Radix Eleutherococci 2002; ES-
OP Monographs 2003; Farnsworth et al. 1985). In TCM, it is used
o reinforce qi, invigorate the function of the spleen and kidney,
nd anchor the mind (Radix et Rhizoma seu Caulis Acanthopanacis
enticosi (Ciwaujia) 2005). Moreover, a large body of evidence in-
icated possible beneﬁts of Eleutherococcus in the treatment of URT
nfections.
Kan Jang (KJ) is a ﬁxed combination, which is known in Scandi-
avia as the medicinal product “naturmedel” since 1979 and has the
well-established” status in Denmark for the treatment of common
old symptoms (Panossian and Wikman 2012). The clinical eﬃcacy
f this combination has been demonstrated in inﬂuenza (Kulichenko
t al. 2003), sinusitis (Gabrielian et al. 2002), and familial Mediter-
anean fever (Amaryan et al. 2003). In a recent review article, the
linical eﬃcacy of A. paniculata extract and KJ was compared and KJ
ombination demonstrated to be more eﬃcient than the single plant
lone (Panossian and Wikman, 2012).
The primary aim of this study was to show that our previous ob-
ervation with the ADAPT-232 combination consisting of three plant
xtracts, Radix Eleutherococci (ESE), Schisandra Fruit (SFE) and Radix
nd Rhizoma Rhodiolae (RRE) is robust and transferable to other com-
inations such as KJ. We hypothesize that conclusions about synergy
nd antagonism are justiﬁed by interactive downstream signaling
athway analysis. A secondary task of this study was to identify spe-
iﬁc molecular pathways and networks affected by A. paniculata and
. senticosus genuine extracts and their ﬁxed combination, KJ. There-
ore, we analyzed microarray-based transcriptome-wide mRNA ex-
ression proﬁles of the neuroglial cell line T98G after exposure to KJ
nd its single constituents. The choice of T98G cells for our study was
ustiﬁed in our previous publication (Panossian et al. 2013). Interac-
ive pathways downstream analysis was performed with data sets of
igniﬁcantly up- or down-regulated genes. Effects on relevant cellular
unctions and diseases were predicted by Ingenuity Pathway Analysis
IPA) software.
A. Panossian et al. / Phytomedicine 22 (2015) 981–992 983
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taterials and methods
rugs and chemicals
Pharmaceutical grade standardized extracts of A. paniculata and
. senticosus genuine extracts and their ﬁxed combination, KJ, were
anufactured in accordance to ICH Q7A and EMEA guidelines for
ood Agricultural and Collecting Practice (GACP) and Good Manu-
acturing Practice (GMP) of active pharmaceutical ingredients (API),
ig. 1.
The content of plant extracts and their active markers was the
ame in all preparations. Working samples used in experiments were
repared by dilution of stock solutions (30 mg/ml, DMSO) Herba An-
rographidis, (2.7 mg/ml, DMSO) Radix Eleutherococci genuine ex-
racts and their ﬁxed combination KJ (32.7 mg/ml) with appropriate
olumes of phosphate buffered saline solution (PBS). Working solu-
ions of 100 μl were added to 9.9 ml of cell culture to obtain the
ame ﬁnal concentrations of active markers and genuine extract as
n the incubation media of KJ: 30 μg/ml of HA, 32.7 μg/ml of KJ and
.7 μg/ml of RE respectively (Table 1)
The concentration of 32.7 μg/ml (ﬁnal concentration of KJ in in-
ubation media) is based on the results of pharmacokinetic study ofFig. 1. Three-dimensional HPLC ﬁngerprint
Table 1
Concentrations used to treat T98G neuroglial cells for microarray expe
Herbal extract Final
concentration,
μg/ml
Final
concentration of
and, μg/ml
m
co
ng
Andrographolide 0.70 0.70 = 2 μM 35
0.70 0.70 = 2 μM 32
APE 30.00 0.70 = 2 μM 35
30.00 0.70 = 2 μM 23
KJ 32.70 0.70 = 2 μM 38
32.70 0.70 = 2 μM 32
ESE 2.70 – 32
2.70 – 34J -derived andrographolide in human blood plasma, where it was
etected in concentrations of ∼ 0.7 μg/ml = 2 μM (Panossian et al.,
000).
The concentrations of the total extracts of both herbal ingredi-
nts and their active constituents were compatible is all test samples:
.g. the ﬁnal concentration of andrographolide is the same (2 μM,
00 μg/l in all test samples containing andrographolide, namely in
A extract, and KJ. Similarly, eleutheroside E concentrationswere cal-
ulated based of the results of the HPLC analysis of its content in gen-
ine extracts and KJ combination. The concentrations of genuine ex-
racts have been calculated using speciﬁcations of KJ to ensure that
hey correspond to therapeutically effective doses.
ell culture
The human neuroglial cell line T98G was purchased from the
merican Type Culture Collection (ATCC, CRL-1690). Cells were
rown in DMEM + GlutaMAX-I (Gibco, Darmstadt, Germany) with
0% fetal bovine serum (Gibco, Darmstadt) and 1% penicillin/
treptomycin (Gibco). They were passaged twice a week and main-
ained in a 37 °C incubator in a humidiﬁed atmosphere with 5%of KJ detection from 200 to 400 nm.
riments.
RNA
ncentration,
/μl
Amount for
microarray, μl;
1 μg
Amount for cDNA,
μl; 2 μg
4.7 2.82 5.64
3.6 3.09 6.18
7.6 2.80 5.60
5.3 4.25 8.50
5.1 2.60 5.20
7.8 3.05 6.10
3.0 3.09 6.18
2.8 2.92 5.84
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Fig. 2. Venn diagrams of deregulated genes induced by the treatment of neuroglia cells with (a) APE, ESE alone and (b) APE, ESE in KJ. Genes uniquely deregulated by each extract
alone (55 by APE and 170 by ESE) and 111 unique genes deregulated by KJ show antagonistic and synergistic interactions of ESE and APE in KJ. Overlapping sections show common
genes deregulated by these ingredients in the KJ combination.
Table 2
Expression of genes commonly deregulated by APE, ESE and KJ.
Genes APE ESE KJ Expected sum
ACOT7 −1.586 −1.516 −1.723 −3.102
APOBEC3F −1.444 −1.558 −1.647 −3.002
APOBEC3G −1.619 −1.376 −1.705 −2.995
ASS1 −1.630 −1.366 −1.834 −2.996
CXCL12 1.564 −1.500 1.591 0.064
F2RL2 2.211 1.454 2.594 3.665
GBP1 −1.729 −1.464 −1.636 −3.193
GLDN 1.569 1.464 1.772 3.033
HIST1H2AC −1.765 −1.424 −1.558 −3.189
KRT18 −1.796 −1.591 −2.166 −3.387
LYPD1 −1.699 −1.464 −1.591 −3.163
NAMPT 1.860 −1.647 2.151 0.213
PSMB8 −1.597 −1.495 −1.439 −3.092
RCAN1 −1.647 −1.376 −1.444 −3.023
RNY4 2.092 1.361 1.510 3.453
SLC6A1 1.449 1.905 1.586 3.354
SLCO2B1 2.990 1.449 3.238 4.439
SRXN1 2.063 1.361 1.952 3.424
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aCO2. All experiments were conducted using cells in the logarithmic
growth phase.
Drug treatment
T98G cells were seeded 24 h before treatment on 6-well plates in
a density of 150,000 cells per well. The next day, old medium was
removed and cells were treated in a ﬁnal volume of 10 ml.
The ethanol content was 0.8% for cells treated with isolated
compounds and vehicle-treated control cells (test sample Z). Twoechnical replicates were performed for each sample. Cells were in-
ubated with the test substances for 24 h at 37 °C and then subjected
o RNA isolation.
RNA isolation and quality control
Cells were harvested after 24 h of treatment. Total RNA was iso-
ated using InviTrap Spin Universal RNA Mini kit (Stratec Molecular,
erlin, Germany) and dissolved in RNAse free-water. The RNA of the
wo technical replicates was pooled (1:1) resulting in one sample
or each treatment/control. The quality of total RNA was checked by
el analysis using the Total RNA Nano chip assay on an Agilent 2100
ioanalyzer (Agilent Technologies, Berlin, Germany). All samples
ere of highest quality with RNA integrity number values of 10.
ene expression proﬁling
Microarray hybridizations were performed at the Institute of
olecular Biology (Mainz, Germany). Whole Human Genome RNA
hips (8 × 60 K Agilent) were used for gene expression proﬁling.
robe labeling and hybridization procedures were carried out follow-
ng the One-Color Microarray-Based Gene Expression Analysis Pro-
ocol (http://www.chem.agilent.com/Library/usermanuals/Public/G
14090040_GeneExpression_One-color_v6.5.pdf). Brieﬂy, total RNA
as labeled and converted to cDNA. Then, ﬂuorescent cRNA (Cyanine
-CTP) was synthesized and puriﬁed using the QIAgen RNeasy Kit
Hilden, Germany). After fragmentation of the cRNA, samples were
ybridized for 17 h at 65 °C. Microarray slides were washed and
canned with the Agilent Microarray Scanning system. Images were
nalyzed and datawas extracted. The backgroundwas subtracted and
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Fig. 3. Conditional “biological signatures” of (a) APE, (b) ESE and (c) KJ; (d) shows new synergy-derived elements of the KJ signature. Thesewindows show the results of downstream
effects analysis to visualize biological trends in these experiments and to predict the effect of gene expression changes in these datasets on biological processes and diseases. Color-
coded heatmaps identify functions and diseases that are expected to increase or decrease. Details see ‘Materials and methods’ section.
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rata was normalized using the standard procedures of Agilent Fea-
ure Extraction Software.
icroarray data analysis
Expression data were further analyzed using Chipster software
http://chipster.csc.ﬁ/) to ﬁlter genes by varying expression and sig-
iﬁcance. These steps included ﬁltering genes that were up- or down-
egulated by one to three times the standard deviation (depending on
he total number of extremely up- or down-regulated genes). A sub-
equent assessment of signiﬁcance using empirical Bayes t-test fur-
her narrowed the pool of genes. All genes further considered showed
signiﬁcant difference from the control with at least p-value <0.05.
inally, ﬁltered data were subjected to Ingenuity Pathway Analysis for
ore analysis to determine networks and pathways inﬂuenced by the
rug treatments (http://www.ingenuity.com/).
nteractive Pathway Analysis (IPA) of complex ‘omics’ data
http://www.ingenuity.com/)
Downstream effect analysis enables to visualize biological trends
n microarray experiments and predicts gene expression changes in
hese datasets during biological processes. Color-coded heatmaps vi-
ualize increased or decreased gene expressions. Downstream effect
nalysis is based on expected causal effects between genes and func-
ions. The expected causal effects are derived from the literature com-
iled in the Ingenuity® Knowledge Base. The analysis examines genes
n the datasets that are known to affect functions, compares the genes
irection of change to expectations derived from the literature. Then,redictions are made for each function based on the direction of
hange.
The direction of change is the gene expression in the experimental
amples relative to a control. If the direction of change is consistent
ith the literature across most genes, IPA predicts that the function
ill increase in the experimental sample. Mostly inconsistent with
he literature, IPA predicts that the function will decrease in the ex-
erimental sample. IPA uses the z-score algorithm to make predic-
ions. The z-score algorithm is designed to reduce the chance that
andom data will generate signiﬁcant predictions.
The color of the squares in the heatmap shows the direction of
hange for the function, based on the regulation z-score:
• Orange – The z-score is positive. IPA predicts that the biological
process or disease is trending towards an increase. Z-scores ≥2
indicate that the function is statistically signiﬁcantly increased.
• Blue – The Z-score is negative. IPA predicts that the biological pro-
cess or disease is trending towards a decrease. Z-scores ≤-2 indi-
cate that the function is statistically signiﬁcantly decreased.
The intensity of the colors indicates the prediction strength.
The size of the squares in the heatmap reﬂects the associated -
og of the calculated p-value. Larger squares indicate more signiﬁcant
verlap between the genes perturbed in the dataset and the func-
ion or disease. The p-value is a measure of the likelihood that the
ssociation between a set of genes in a dataset and a related func-
ion is due to random association. The smaller the p-value (which
eans a larger −log of that value), the less likely that the associa-
ion is random and the more signiﬁcant the association. In general,
-values <0.05 (−log = 1.3) indicate a statistically signiﬁcant, non-
andom association.
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Fig. 4. Predictable effects on molecular networks associated with encephalitis: (a) APE, (b) ESE and (c) KJ; (d) synergy-derived elements of KJ signature.
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Venn diagramswere generated by software at the websites http://
bioinfogp.cnb.csic.es/tools/venny/; http://www.bioinformatics.lu/
venn.php; http://bioinformatics.psb.ugent.be/webtools/Venn/.
Results
Effects of single herbal extracts and their ﬁxed combination on mRNA
microarray proﬁles
A microarray-based transcriptome-wide mRNA expression analy-
sis was performed to identify possible targets of the tested substances
in T98G cells. The cells were treated with test substances for 24 h in
two technical replicates before total RNA was isolated and pooled for
microarray hybridization. Signiﬁcantly deregulated genes were iden-
tiﬁed compared to untreated controls (p< 0.05) bymeans of Chipster
software analysis.
IPA was performed with data sets of signiﬁcantly up- or down-
regulated genes: ESE and APE signiﬁcantly deregulate 207 and 211
genes correspondingly; 36 deregulated genes were common for both
extracts. In total, 382 genes were deregulated by their ﬁxed combi-
nation KJ (Fig. 2a). However, only 250 genes were deregulated by KJ
(Fig. 2b). Among these 250 genes, 111 genes were unique for the KJombination and not affected by ESE and APE. This is presumably due
o synergistic interactions of molecular networks affected by ESE and
PE. Meanwhile, 188 genes deregulated by ESE and 73 genes deregu-
ated by APE, if tested alone. In total, 243 geneswere not up- or down-
egulated by KJ. This may result from antagonistic integrations of ESE
nd APE extracts, if applied as combination.
The Venn diagrams in Fig. 2 show the number of uniquely dereg-
lated genes for each extract in comparison to the number of com-
only deregulated genes.
The effect of two ingredients on expression of a particular gene
s not additive. The fold change of expression of 18 common genes
eregulated by KJ was not additive and not the sum of fold changes
y APE and ESE as expected, if they were combined in KJ (Table 2). For
xample, no effect of KJ on CXCL12 and NAMPT genes expression can
e predicted based on the sum of the effects of EPE and ESE. However,
oth of them were upregulated by KJ (Table 2).
However, qualitatively different effects of APE, ESE and their ﬁxed
ombination KJ was observed for RNA microarray proﬁles of dereg-
lated genes in T98G cells (“Supplementary” Tables 1 and 2). Syner-
istic effects of two plant extracts were obvious, when the effects of
he combination (KJ) and the single ingredients (APE and ESE) were
ompared in the mRNA microarray proﬁles of deregulated genes.
his can be illustrated in the corresponding molecular networks
Figs. 4a–d, 5a–f, 6a–e), intracellular signaling pathways (Fig. 7a–c
nd 8a–e) and predicted effects (“Supplementary” Tables 3 and 4)
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Fig. 5. Effects onmolecular network associatedwith anti-inﬂammatory and antimicrobial response and cancer: (a) APE, (b) ESE and (c) KJ; (d) shows new synergy-derived elements
of KJ signature, (e) and (f) predicted effects.
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Fig. 6. Effects onmolecular networks associated with cellular development, nervous system development and functions: (a) APE, (b) ESE and (c) KJ; (d) shows new synergy-derived
elements of KJ signature, (e) predicted effects.
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Fig. 7. The most signiﬁcantly affected canonical pathways: (a) APE, (b) ESE, (c) KJ.
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as well as physiological, cellular functions and associated diseases
Fig. 3a–d).
As an example of synergistic interactions in a molecular network,
e found that ESE alone has no effect on that network, while KJ
eregulated 11 genes with predictable inhibitory effect on infection,
hile APE regulated only 5 genes, which are activated in encephali-
is. It might be speculated that APE in combinationwith ESEmay have
etter therapeutic effect, since more targets are affected.
Similar observations were made for other networks including sig-
iﬁcantly affected (p < 0.05; −log = 1.3) networks with the pre-
ictable (Z-score > 2) effects in infectious and chronic inﬂammatory
isorders (Fig. 5) and neurological movement disorder (Fig. 6) at a
igniﬁcance level of p < 0.05 (−log = 1.3) and a Z-score of >2.
ownstream effects analyses of deregulated sets of genes by Ingenuity
athway Analysis (IPA) software and predicted effects of KJ on cellular
nd physiological functions and associated deceases
As a next step, we focused on downstream effect analyses of
eregulated sets of genes by IPA software with the purpose to un-
overmolecular targets of APE, ESE, KJ and andrographolide, themain
ctive constituents of APE. We investigated the signaling pathways
nd molecular networks, which they regulate, and estimated their
redictable effects on physiological and cellular functions and asso-
iated diseases.
The most signiﬁcantly affected canonical pathways deregulated
y KJ and APE were interferon-signaling and NRF2-mediated oxida-
ive stress response pathways (Fig. 7). Inhibition of NRF2-mediatedxidative stress response is in line with many publications, where
nti-inﬂammatory and antioxidant effects of APE and ESE were
emonstrated (Panossian and Wikman 2012; Herba Andrographidis
002; Radix Eleutherococci 2002).
The predicted inhibition of the interferon-signaling pathway by
J and APE was due to signiﬁcant downregulation of six genes: IFI35,
FIT1, IFITM1, IFITM3, IRF1, PSMB8 encoding interferon-induced pro-
ein 35, interferon-induced protein with tetratricopeptide repeats
, interferon induced transmembrane protein 1, interferon induced
ransmembrane protein 3, interferon regulatory factor 1, and protea-
ome subunit beta type 8, respectively. On the other hand, ESE down-
egulated JAK1, which encodes Janus kinase 1, which is upstream of
he interferon-signaling cascade (Fig. 8).
The predicted (Z-score> 2) effects in encephalitis (Fig. 4 and “Sup-
lementary” Table 4), and neurological movement disorder (Fig. 6
nd “Supplementary” Table 3) are based on changes of gene expres-
ion in the experimental samples relative to the control.
iscussion
ow to detect synergistic and antagonistic interactions of herbal
ombinations extracts by DNA microarray hybridization?
Two-set Venn diagrams were used in present study for the anal-
sis of ﬁxed combinations of two plant extracts. The combination of
hree plant extracts can be analyzed by using the tree-set Venn dia-
ram model as previously reported by us (Panossian et al. 2013). As
n example, DNA microarray data from our previous study with a
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Fig. 8. Activation of the interferon pathway (d) and predicted inhibitory effects of APE (a), ESE (b), KJ (c) and (e) on various steps of this signaling pathway.
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dcombination of three herbs (Panossian et al. 2013) are showed in
Fig. 9. The sum of deregulated genes by Radix Eleutherococci (ESE),
Schisandra Fruit (SFE) and Radix et Rhizome Rhodiola (RRE) genes is
778 (Fig. 9a). However, their ﬁxed combination (ADAPT) deregulated
only 297 genes (Fig. 9b). Among these 297 genes, 86 genes were
unique only for the KJ combination and not affected by ESE, SFE and
RRE and APE. This is presumably due to synergistic interactions of
molecular networks affected by ESE. These 206 genes were deregu-
lated due to synergistic interaction of ingredients. Meanwhile, 241
genes deregulated by ESE, 222 genes deregulated by SFE and 249
genes deregulated by RRE were not deregulated by ADAPT. That is
a result of antagonistic integrations of ESE, SFE and RRE extracts, if
applied in combination.
The Venn diagrams in Fig. 9 show the number of uniquely dereg-
ulated genes for each treatment extract in comparison to the number
of commonly deregulated genes.
Unlike to chemical reactions, where the chemical properties of pu-
riﬁed compounds remain the same as in their mixture with otherhemicals, biological activities of combinations are different from
hose of their single ingredients (Fig. 3). In fact, it is a “newborn”
nique biologically active substance, a hybrid of the “parent” ingre-
ients. The expectations to have a sum of biological activities from
wo ingredients are elusive. The biological activity of their combina-
ion could be qualitatively different.
eculiarities of KJ ﬁxed combination
Downstream effect analysis of mRNA microarray data enables to
redict pharmacological effects of new plant extract combinations on
ellular and physiological functions and possible indications for vari-
us diseases and ﬁnally to conclude, whether an extract combination
s really justiﬁed.
The most signiﬁcantly affected canonical pathways deregulated
y KJ and APE were interferon-signaling pathways (Figs. 7 and 8).
ownregulation of expression of these genes was associated with
ownregulation of expression of corresponding proteins involved in
A. Panossian et al. / Phytomedicine 22 (2015) 981–992 991
Fig. 9. Venn diagrams of deregulated genes induced by the treatment of neuroglia cells with (a) ESE, SFE and RRE alone and (b) ESE, SFE, RRE in ADAPT. The number of unique
genes deregulated by each extract alone (241 by ESE, 222 by SFE and 249 by RRE) and 206 uniquely deregulated genes by ADAPT showed antagonistic and synergistic interactions
of ESE, SFE and RRE in ADAPT. Overlapping sections show commonly deregulated genes by these ingredients in the ADAPT combination.
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Hnitiating immune responses, especially in antiviral and antitumor ef-
ects. Inhibition of IFN-gamma signaling pathways may represent an
ppropriate treatment goal, if interferon is overproduced, e.g. in sep-
is (Dejager et al. 2014) and various autoimmune diseases, including
kin diseases rheumatoid arthritis, multiple sclerosis, corneal trans-
lant rejection, and various autoimmune skin diseases such as pso-
iasis, alopecia areata, vitiligo, acne vulgaris, systemic lupus erythe-
atosus, and others (Skurkovich and Skurkovich 2006; Lateef and Pe-
ria 2010).
Upstream effect analysis showed inhibition of IFN-α, IFN-β , IFNB1
nd IFNG by KJ and APE that is in line with several studies with
solated cells (Burgos et al. 2005; Parichatikanond et al. 2010), but
n contradiction with the results of few others in vitro (Panossian
t al. 2002; Denzler et al. 2010) and in vivo studies, where the im-
unostimulatory effect of Andrographis was demonstrated (Puri et
l. 1993). An explanation of contradictory results might be due to dif-
erences in test systems (isolated cell lines, whole blood and experi-
ents in vivo), various concentrations and presence of the bacterial
PS in Herba Andrographidis extracts (Denzler et al. 2010). Many im-
unostimulatory extracts appear to contain LPS, likely from the lysis
f endophytic bacteria, which have been identiﬁed in the tissues of
very living plant known (Strobel and Daisy 2003; Rosenblueth and
artinez-Romero 2006). It can be speculated that low concentrations
f APE cause immunostimulatory LPS effects, while at higher concen-
rations inhibitory effects of andrographolide and other Andrographis
aniculata secondary metabolites are dominant.
The results of this study clearly show that the KJ combination
s potentially more active than APE or ESE to inhibit IFN signaling
nd presumably more eﬃcient to treat diseases associated with in-
erferon overexpression.
Synergy derived predicted beneﬁcial effects of the KJ combination
ay be expected in encephalitis and neurological movement disor-
ers.
Though, microarray analysis did not provide a ﬁnal proof that the
enes induced by KJ, APE and ESE are indeed responsible for the phys-
ological effects observed in humans following their oral administra-
ion, it provided insights into putative genetic signaling pathways for
uture research and possible implementation into practice.
onclusions
Analysis of mRNA microarray data from neuroglial T98G cells and
he comparison proﬁles of genes regulated by plant extracts and their
xed herbal formulationmight be a usefulmethod for the assessmentf synergistic and antagonistic interactions of herbal extracts in hu-
an organism. Downstream effect analysis of mRNAmicroarray data
nables to predict, whether a combination of various extracts is jus-
iﬁed. We conclude that the combination of APE and ESE in KJ formu-
ation is most likely justiﬁed.
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